Skip to content

Ixcela

At-home gut health blood test with dietitian care

Raised to date

$130K

of $1.5M offered across 1 Form D filing

Still open
$1.4M
Investors
3
Last filed
Mar 30, 2026

About

Ixcela is a gut-health diagnostics and virtual care company founded by MIT-trained biochemists Erika Ebbel Angle and Wayne Matson. It sells a proprietary at-home test that measures metabolites associated with gut microbiome function from a fingerprick blood sample, and pairs the results with medically supervised Registered Dietitians who build personalized nutrition and lifestyle plans. The company markets the category as Internal Fitness and reports that 89% of patients in its studies saw improved overall well-being. Its services are billed through major commercial insurance plans as well as HSA/FSA and credit card.

Measures gut microbiome performance through blood metabolites from a fingerprick rather than a stool sample, then routes the result into a licensed-dietitian virtual clinic that is covered by commercial insurance.

Funding

  • Security to be acquiredFiled Mar 30, 2026Form D
    $130K/ $1.5M

Product

Ixcela at-home gut health test

At-home diagnostic test

A proprietary at-home test that measures metabolites tied to gut microbiome function from a small fingerprick blood sample, producing a report on the underlying drivers of sleep, energy and digestive issues.

  • Fingerprick blood sample collected at home or in the office
  • Metabolite panel reflecting gut microbiome performance
  • Personalized nutrition and lifestyle recommendations from licensed Registered Dietitians

Built for

Adults with unresolved digestive, energy, sleep, metabolic or weight concerns, plus healthcare providers referring such patients

People on file